维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

4篇 您的检索式：作者名="G.Fitzgerald"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Trajectories of Alcohol Consumption Following Liver Transplantation显示文摘	A.DiMartini M. A.Dew N.Day M. G.Fitzgerald B. L.Jones M. E.DeVera P.Fontes	2010	American Journal of Transplantation2010，，10：	1
	2	Early Trajectories of Depressive Symptoms after Liver Transplantation for Alcoholic Liver Disease Predicts Long‐Term Survival显示文摘	A.DiMartini M. A.Dew D.Chaiffetz M. G.Fitzgerald M. E.deVera P.Fontes	2011	American Journal of Transplantation2011，，6：	1
	3	Trajectories of Alcohol Consumption Following Liver Transplantation显示文摘	A.DiMartini M. A.Dew N.Day M. G.Fitzgerald B. L.Jones M. E.DeVera P.Fontes	2010	American Journal of Transplantation2010，，10：	1
	4	Treatment of unresectable malignant pleural mesothelioma in 2021: emerging standards in immunotherapy显示文摘Patients with unresectable malignant pleural mesothelioma(MPM)have historically poor outcomes and treatment,and their treatments have been limited to palliative chemotherapy.Recent efforts to improve prognosis for these patients by adding angiogenesis inhibitors to chemotherapy led to significant benefits.However,the emergence of immunotherapy combinations for the front-line treatment has upended the standard of care and has led to the first new FDA approvals for the treatment of MPM in nearly two decades.This review aims to cover the main clinical trials in unresectable MPM with VEGF inhibitors and immunotherapy which have led to paradigm shifts in current practice.Ongoing clinical trials exploring the combination of chemo and immunotherapies show a great deal of promise,and continued support for ambitious,large-scale well-designed trials remain vital for defining the future outcomes of patients diagnosed with MPM.	Bailey G.Fitzgerald Lee M.Krug	2021	Journal of Cancer Metastasis and Treatment2021，7，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费